Diabetic Macular Edema (DME) Global Market Report 2025

Global Diabetic Macular Edema (DME) Market Report 2025

Diabetic Macular Edema (DME) Global Market Report 2025 - By Treatment (Anti-VEGF Therapy, Corticosteroids, Laser Therapy, Surgical Intervention ), By Disease Stage (Early Stage, Moderate Stage, Advanced Stage ), By Patient Demographics (Adults, Elderly, Children), By Route Of Administration (Intravitreal Injection, Topical, Systemic), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Market Size, Trends, And Global Forecast 2025-2034

Name: Diabetic Macular Edema (DME) Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Diabetic Macular Edema (DME) Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : March 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Diabetic Macular Edema (DME) Global Market Report 2025

Proud Members Of

What Is Covered Under Diabetic Macular Edema (DME) Market?

Diabetic macular edema (DME) is a complication of diabetes that occurs when fluid accumulates in the macula, the central part of the retina responsible for sharp vision. This swelling is caused by damaged blood vessels leaking fluid and proteins into the retinal tissue, leading to vision impairment or blindness if left untreated. DME is a common cause of vision loss in diabetic patients and is associated with diabetic retinopathy.

The main treatments of diabetic macular edema (DME) are anti-VEGF therapy, corticosteroids, laser therapy, and surgical intervention. Anti-VEGF therapy works by inhibiting vascular endothelial growth factor (VEGF), a protein responsible for abnormal blood vessel growth and retinal leakage, which contribute to diabetic macular edema (DME). The disease progresses through stages such as early stage, moderate stage, and advanced stage. Patient demographics are categorized by age group, including adults, Elderly, and children. Routes of administration consist of intravitreal injection, topical, and systemic methods, and it is distributed by hospital pharmacies, retail pharmacies, and online pharmacies.

What Is The Diabetic Macular Edema (DME) Market Size 2025 And Growth Rate?

The diabetic macular edema (DME) market size has grown steadily in recent years. It will grow from $4.67 billion in 2024 to $4.89 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to rise in prevalence of diabetes, increase in edema-related disorders, growth in prevalence of diabetic eye diseases, surge in geriatric population, and increase cases of blindness.

What Is The Diabetic Macular Edema (DME) Market Growth Forecast?

The diabetic macular edema (DME) market size is expected to see steady growth in the next few years. It will grow to $5.82 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to increasing healthcare access, rising government healthcare funding, rising awareness about diabetic complications, growing adoption of telemedicine for eye care, and expansion of specialized diabetic eye care centers. Major trends in the forecast period include development of anti-VEGF therapies, adoption of corticosteroid implants, advancements in drug delivery systems, innovation in retinal laser treatments, AI-powered diagnostic tools, and adoption of minimally invasive surgical techniques.

Diabetic Macular Edema (DME) Market Size and growth rate 2025 to 2029: Graph

How Is The Diabetic Macular Edema (DME) Market Segmented?

The diabetic macular edema (DME) market covered in this report is segmented –

1) By Treatment: Anti-VEGF Therapy, Corticosteroids, Laser Therapy, Surgical Intervention

2) By Disease Stage: Early Stage, Moderate Stage, Advanced Stage

3) By Patient Demographics: Adults, Elderly, Children

4) By Route Of Administration: Intravitreal Injection, Topical, Systemic

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Anti-VEGF Therapy: Monoclonal Antibodies, Recombinant Protein-Based Therapies

2) By Corticosteroids: Intravitreal Steroid Injections, Injectable Sustained-Release Corticosteroids

3) By Laser Therapy: Focal Laser Photocoagulation, Panretinal Photocoagulation

4) By Surgical Intervention: Vitrectomy, Membrane Peeling

Book your 30 minutes free consultation with our research experts

What Is Driving The Diabetic Macular Edema (DME) Market? Rising Diabetes Prevalence And Its Impact On Eye Health

The increase in prevalence of diabetes is expected to drive the growth of the diabetic macular edema (DME) market going forward. The increasing prevalence of diabetes is attributed to factors such as sedentary lifestyles, unhealthy dietary habits, rising obesity rates, aging populations, and genetic predisposition. Diabetes causes diabetic macular edema by damaging retinal blood vessels, leading to leakage of fluid into the macula and resulting in swelling. For instance, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people globally were living with diabetes. This number is expected to more than double, reaching 1.3 billion people by 2050. Therefore, the increase in prevalence of diabetes is driving the growth of the diabetic macular edema (DME) market.

Who Are The Major Players In The Global Diabetic Macular Edema (DME) Market?

Major companies operating in the diabetic macular edema (DME) market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Novartis AG, Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals, Carl Zeiss Meditec AG, Bausch & Lomb, Santen Pharmaceutical Co. Ltd., Carl Zeiss AG, Topcon Corporation, Ypsomed AG, ARKRAY Inc, Hugel Inc., Optos plc, Noven Pharmaceuticals Inc., Alimera Sciences Inc., Allergan plc.

What Are The Key Trends Of The Global Diabetic Macular Edema (DME) Market? Advancements In Drug Therapies For Improved Patient Outcomes

Major companies operating in the diabetic macular edema (DME) treatment market are focusing on technological advancements, such as advanced drug therapies, to improve the management and treatment outcomes for patients. Advanced drug therapies are innovative treatments that use new technologies and research to better treat complex health conditions. These therapies focus on improving effectiveness, reducing side effects, and offering better outcomes for patients. For instance, in March 2022, Novartis AG, a Switzerland-based pharmaceutical company, announced the European Commission's approval of Beovu for treating visual impairment due to diabetic macular edema (DME). The approval was based on Phase III KESTREL and KITE study results, demonstrating Beovu's comparable effectiveness to aflibercept in improving vision after one year. Notably, over half of the Beovu-treated patients maintained a 12-week treatment schedule, with fewer instances of retinal fluid compared to aflibercept.

What Are Latest Mergers And Acquisitions In The Diabetic Macular Edema (DME) Market? Merck's Strategic Acquisition To Advance Ophthalmology Innovations

In July 2024, Merck & Co Inc, a US-based pharmaceutical company, acquired Eyebiotech Limited for $1.3 billion. This acquisition allows Merck & Co. to strengthen its portfolio, boost research capabilities, and secure access to Restoret (EYE-103), a promising treatment for diabetic macular edema (DME) and treatment-naive neovascular age-related macular degeneration (AMD), positioning the company to address significant unmet needs in ophthalmology. Eyebiotech Limited (EyeBio) is a UK-based biotechnology company specializing in ophthalmology.

What Is The Regional Outlook For The Global Diabetic Macular Edema (DME) Market?

North America was the largest region in the diabetic macular edema (DME) market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic macular edema (DME) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the diabetic macular edema (DME) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Diabetic Macular Edema (DME) Market?

The diabetic macular edema (DME) market consists of revenues earned by entities by providing services such as retinal imaging, fluorescein angiography, visual acuity testing, and laser therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The diabetic macular edema market includes sales of ranibizumab, aflibercep, fluocinolone acetonide intravitreal implant, and dexamethasone intravitreal implant. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Diabetic Macular Edema (DME) Industry?

The diabetic macular edema (DME) market research report is one of a series of new reports from The Business Research Company that provides diabetic macular edema (DME) market statistics, including the diabetic macular edema (DME) industry's global market size, regional shares, competitors with a diabetic macular edema (DME) market share, detailed diabetic macular edema (DME) market segments, market trends and opportunities, and any further data you may need to thrive in the diabetic macular edema (DME) industry. This diabetic macular edema (DME) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Diabetic Macular Edema DME Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$4.89 billion
Revenue Forecast In 2034	$5.82 billion
Growth Rate	CAGR of 4.4% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The diabetic macular edema (DME) market covered in this report is segmented – 1) By Treatment: Anti-VEGF Therapy, Corticosteroids, Laser Therapy, Surgical Intervention 2) By Disease Stage: Early Stage, Moderate Stage, Advanced Stage 3) By Patient Demographics: Adults, Elderly, Children 4) By Route Of Administration: Intravitreal Injection, Topical, Systemic 5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Anti-VEGF Therapy: Monoclonal Antibodies, Recombinant Protein-Based Therapies 2) By Corticosteroids: Intravitreal Steroid Injections, Injectable Sustained-Release Corticosteroids 3) By Laser Therapy: Focal Laser Photocoagulation, Panretinal Photocoagulation 4) By Surgical Intervention: Vitrectomy, Membrane Peeling
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Novartis AG, Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals, Carl Zeiss Meditec AG, Bausch & Lomb, Santen Pharmaceutical Co. Ltd., Carl Zeiss AG, Topcon Corporation, Ypsomed AG, ARKRAY Inc, Hugel Inc., Optos plc, Noven Pharmaceuticals Inc., Alimera Sciences Inc., Allergan plc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Diabetic Macular Edema (DME) Market Characteristics

3. Diabetic Macular Edema (DME) Market Trends And Strategies

4. Diabetic Macular Edema (DME) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Diabetic Macular Edema (DME) Growth Analysis And Strategic Analysis Framework

5.1. Global Diabetic Macular Edema (DME) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Diabetic Macular Edema (DME) Market Growth Rate Analysis

5.4. Global Diabetic Macular Edema (DME) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Diabetic Macular Edema (DME) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Diabetic Macular Edema (DME) Total Addressable Market (TAM)

6. Diabetic Macular Edema (DME) Market Segmentation

6.1. Global Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Anti-VEGF Therapy

Corticosteroids

Laser Therapy

Surgical Intervention

6.2. Global Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Early Stage

Moderate Stage

Advanced Stage

6.3. Global Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adults

Elderly

Children

6.4. Global Diabetic Macular Edema (DME) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intravitreal Injection

Topical

Systemic

6.5. Global Diabetic Macular Edema (DME) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

6.6. Global Diabetic Macular Edema (DME) Market, Sub-Segmentation Of Anti-VEGF Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monoclonal Antibodies

Recombinant Protein-Based Therapies

6.7. Global Diabetic Macular Edema (DME) Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intravitreal Steroid Injections

Injectable Sustained-Release Corticosteroids

6.8. Global Diabetic Macular Edema (DME) Market, Sub-Segmentation Of Laser Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Focal Laser Photocoagulation

Panretinal Photocoagulation

6.9. Global Diabetic Macular Edema (DME) Market, Sub-Segmentation Of Surgical Intervention, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Vitrectomy

Membrane Peeling

7. Diabetic Macular Edema (DME) Market Regional And Country Analysis

7.1. Global Diabetic Macular Edema (DME) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Diabetic Macular Edema (DME) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Diabetic Macular Edema (DME) Market

8.1. Asia-Pacific Diabetic Macular Edema (DME) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Diabetic Macular Edema (DME) Market

9.1. China Diabetic Macular Edema (DME) Market Overview

9.2. China Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Diabetic Macular Edema (DME) Market

10.1. India Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Diabetic Macular Edema (DME) Market

11.1. Japan Diabetic Macular Edema (DME) Market Overview

11.2. Japan Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Diabetic Macular Edema (DME) Market

12.1. Australia Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Diabetic Macular Edema (DME) Market

13.1. Indonesia Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Diabetic Macular Edema (DME) Market

14.1. South Korea Diabetic Macular Edema (DME) Market Overview

14.2. South Korea Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Diabetic Macular Edema (DME) Market

15.1. Western Europe Diabetic Macular Edema (DME) Market Overview

15.2. Western Europe Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Diabetic Macular Edema (DME) Market

16.1. UK Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Diabetic Macular Edema (DME) Market

17.1. Germany Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Diabetic Macular Edema (DME) Market

18.1. France Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Diabetic Macular Edema (DME) Market

19.1. Italy Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Diabetic Macular Edema (DME) Market

20.1. Spain Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Diabetic Macular Edema (DME) Market

21.1. Eastern Europe Diabetic Macular Edema (DME) Market Overview

21.2. Eastern Europe Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Diabetic Macular Edema (DME) Market

22.1. Russia Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Diabetic Macular Edema (DME) Market

23.1. North America Diabetic Macular Edema (DME) Market Overview

23.2. North America Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Diabetic Macular Edema (DME) Market

24.1. USA Diabetic Macular Edema (DME) Market Overview

24.2. USA Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Diabetic Macular Edema (DME) Market

25.1. Canada Diabetic Macular Edema (DME) Market Overview

25.2. Canada Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Diabetic Macular Edema (DME) Market

26.1. South America Diabetic Macular Edema (DME) Market Overview

26.2. South America Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Diabetic Macular Edema (DME) Market

27.1. Brazil Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Diabetic Macular Edema (DME) Market

28.1. Middle East Diabetic Macular Edema (DME) Market Overview

28.2. Middle East Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Diabetic Macular Edema (DME) Market

29.1. Africa Diabetic Macular Edema (DME) Market Overview

29.2. Africa Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Diabetic Macular Edema (DME) Market Competitive Landscape And Company Profiles

30.1. Diabetic Macular Edema (DME) Market Competitive Landscape

30.2. Diabetic Macular Edema (DME) Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Diabetic Macular Edema (DME) Market Other Major And Innovative Companies

31.1. Novartis AG

31.2. Boehringer Ingelheim International GmbH

31.3. Regeneron Pharmaceuticals

31.4. Carl Zeiss Meditec AG

31.5. Bausch & Lomb

31.6. Santen Pharmaceutical Co. Ltd.

31.7. Carl Zeiss AG

31.8. Topcon Corporation

31.9. Ypsomed AG

31.10. ARKRAY Inc

31.11. Hugel Inc.

31.12. Optos plc

31.13. Noven Pharmaceuticals Inc.

31.14. Alimera Sciences Inc.

31.15. Allergan plc

32. Global Diabetic Macular Edema (DME) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diabetic Macular Edema (DME) Market

34. Recent Developments In The Diabetic Macular Edema (DME) Market

35. Diabetic Macular Edema (DME) Market High Potential Countries, Segments and Strategies

35.1 Diabetic Macular Edema (DME) Market In 2029 - Countries Offering Most New Opportunities

35.2 Diabetic Macular Edema (DME) Market In 2029 - Segments Offering Most New Opportunities

35.3 Diabetic Macular Edema (DME) Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Diabetic Macular Edema (DME) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Diabetic Macular Edema (DME) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Diabetic Macular Edema (DME) Market, Sub-Segmentation Of Anti-VEGF Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Diabetic Macular Edema (DME) Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Diabetic Macular Edema (DME) Market, Sub-Segmentation Of Laser Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Diabetic Macular Edema (DME) Market, Sub-Segmentation Of Surgical Intervention, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Diabetic Macular Edema (DME) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Diabetic Macular Edema (DME) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Pfizer Inc. Financial Performance

Table 81: Johnson & Johnson Financial Performance

Table 82: F. Hoffmann-La Roche AG Financial Performance

Table 83: Merck & Co. Inc. Financial Performance

Table 84: Bayer AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Diabetic Macular Edema (DME) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Diabetic Macular Edema (DME) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Diabetic Macular Edema (DME) Market, Sub-Segmentation Of Anti-VEGF Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Diabetic Macular Edema (DME) Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Diabetic Macular Edema (DME) Market, Sub-Segmentation Of Laser Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Diabetic Macular Edema (DME) Market, Sub-Segmentation Of Surgical Intervention, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Diabetic Macular Edema (DME) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Diabetic Macular Edema (DME) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Diabetic Macular Edema (DME) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Diabetic Macular Edema (DME) Market, Segmentation By Disease Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Diabetic Macular Edema (DME) Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Pfizer Inc. Financial Performance

Figure 81: Johnson & Johnson Financial Performance

Figure 82: F. Hoffmann-La Roche AG Financial Performance

Figure 83: Merck & Co. Inc. Financial Performance

Figure 84: Bayer AG Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

What Is The Pediatric Imaging Market Overview In 2022?

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the medical aesthetics market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the clinical chemistry market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the medical tourism market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the clinical chemistry market market research report 2022 with industry size, share, segments and market growth

Diabetes Care Devices Global Market Report 2025 – By Type (Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meter), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables), By Type Of Testing (Point Of Care (POC) Testing, Non-Point Of Care (POC) Testing), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Artificial Intelligence in Diabetes Management Global Market Report 2025 – By Device (Diagnostic Devices, Glucose Monitoring Devices, Insulin Delivery Devices, Other Devices), By Techniques (Case-Based Reasoning, Intelligent Data Analysis), By End-Use (Hospitals, Clinics, Home Care Settings, Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Type 1 Diabetes Global Market Report 2025 – By Product Type (Rapid Acting Insulin Analogs, Long-Acting Insulin Analogs, Premix Insulin Analogs, Others Product Types), By Device (Insulin Pump, Insulin Pen, Blood Glucose Meter), By Application (Childrens, Adults), By End-User (Hospital, Research Institutes, Home Care) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Digital Diabetes Management Global Market Report 2025 – By Product & Service (Devices, Application, Data Management Software & Platforms, Services), By Device Type (Handheld Devices, Wearable Devices), By End User (Self/Home Healthcare, Hospitals & Specialty Diabetes Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Type 2 Diabetes Global Market Report 2025 – By Drug Class (Dipeptidyl Peptidase-4 (DPP-, Inhibitors, Glucagon-Like Peptide-1 (GLP-– Receptor Agonists, Thiazolidinediones, Alpha-Glucosidase Inhibitors, Sulfonylureas And Other Insulin Secretagogues, Biguanides, SodiumGlucose Cotransporter 2 Inhibitors, Other Drug Classes), By Application (Glycemic Control, Cardiovascular Safety, Hypoglycemia Avoidance, Other Applications), By End-User (Children, Adults) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Diabetes Pen Global Market Report 2025 – By Product (Insulin Pens, Pen Needles), By Usage (Reusable Injection Pens, Disposable Injection Pens), By Therapy (Insulin, Glucagon-like Peptide-1, Growth Hormones, Fertility, Osteoporosis), By Distribution Channel (Retail Pharmacies, Online Medical Stores, Diabetes Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Liver Cancer Diagnostics Global Market Report 2025 – By Type (Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma, Other Types), By Screening (Laboratory Testing, Imaging, Endoscopy, Biopsy, Other Screenings), By Technology (Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies), By End Use (Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Pharmaceutical And CRO Laboratories) – Market Size, Trends, And Global Forecast 2025-2034

View Report

AI In Medical Diagnostics Global Market Report 2025 – By Component (Software, Services), By Technology (Natural Language Processing, Computer Vision, Machine Learning, Context-Aware Computing, Other Technologies), By Specialty (Brain And Neurological, Oncology, Cardiac And Vascular, Chest And Lung, Obstetrics And Gynecology, Other Specialties), By Application (Computer-Aided Detection, Computer-Aided Diagnosis, Quantitative Analysis Tools, Clinical Decision), By End User (Hospitals, Diagnostics Imaging Centers, Diagnostics Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Diabetic Macular Edema (DME) market?

How will the Diabetic Macular Edema (DME) market drivers and restraints affect the market dynamics? What forces will shape the Diabetic Macular Edema (DME) industry going forward?

The Diabetic Macular Edema (DME) market major growth driver - Rising Diabetes Prevalence And Its Impact On Eye Health. For further insights on the Diabetic Macular Edema (DME) market, request a sample here

What is the forecast market size or the forecast market value of the Diabetic Macular Edema (DME) market?

The Diabetic Macular Edema (DME) market size has grown strongly in recent years. The diabetic macular edema (DME) market size has grown steadily in recent years. It will grow from $4.67 billion in 2024 to $4.89 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to rise in prevalence of diabetes, increase in edema-related disorders, growth in prevalence of diabetic eye diseases, surge in geriatric population, and increase cases of blindness. The diabetic macular edema (DME) market size is expected to see steady growth in the next few years. It will grow to $5.82 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to increasing healthcare access, rising government healthcare funding, rising awareness about diabetic complications, growing adoption of telemedicine for eye care, and expansion of specialized diabetic eye care centers. Major trends in the forecast period include development of anti-VEGF therapies, adoption of corticosteroid implants, advancements in drug delivery systems, innovation in retinal laser treatments, AI-powered diagnostic tools, and adoption of minimally invasive surgical techniques. For further insights on the Diabetic Macular Edema (DME) market, request a sample here

How is the Diabetic Macular Edema (DME) market segmented?

The diabetic macular edema (DME) market covered in this report is segmented –
1) By Treatment: Anti-VEGF Therapy, Corticosteroids, Laser Therapy, Surgical Intervention
2) By Disease Stage: Early Stage, Moderate Stage, Advanced Stage
3) By Patient Demographics: Adults, Elderly, Children
4) By Route Of Administration: Intravitreal Injection, Topical, Systemic
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Anti-VEGF Therapy: Monoclonal Antibodies, Recombinant Protein-Based Therapies
2) By Corticosteroids: Intravitreal Steroid Injections, Injectable Sustained-Release Corticosteroids
3) By Laser Therapy: Focal Laser Photocoagulation, Panretinal Photocoagulation
4) By Surgical Intervention: Vitrectomy, Membrane Peeling For further insights on the Diabetic Macular Edema (DME) market, request a sample here

Which region has the largest share of the Diabetic Macular Edema (DME) market? What are the other regions covered in the report?

Who are the major players in the Diabetic Macular Edema (DME) market?

What are the key trends in the Diabetic Macular Edema (DME) market?

Major trends in the Diabetic Macular Edema (DME) market include Advancements In Drug Therapies For Improved Patient Outcomes. For further insights on the Diabetic Macular Edema (DME) market, request a sample here.

What are the major opportunities in the Diabetic Macular Edema (DME) market? What are the strategies for the Diabetic Macular Edema (DME) market?

For detailed insights on the major opportunities and strategies in the Diabetic Macular Edema (DME) market, request a sample here.

How does the Diabetic Macular Edema (DME) market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Diabetic Macular Edema (DME) market growth and SWOT analysis of the Diabetic Macular Edema (DME) industry, request a sample here.

For detailed insights on Diabetic Macular Edema (DME)'s relation to the overall economy and other similar markets,

What are the latest mergers and acquisitions in the Diabetic Macular Edema (DME) industry? request a sample here.

For detailed insights on the mergers and acquisitions in the Diabetic Macular Edema (DME) industry,

What are the key dynamics influencing the Diabetic Macular Edema (DME) market growth? SWOT analysis of the Diabetic Macular Edema (DME) market. request a sample here.